XCF Global Updates on New Rise Renewables Plant Conversion Progress
XCF Global provided an update on the conversion of its New Rise Renewables Reno Plant remains on schedule. The ongoing transformation of the plant is part of XCF's New Rise Renewables' broader strategy and is intended to enhance production and operational efficiency. XCF's flagship New Rise Reno plant is undergoing a series of upgrades that are designed to optimize plant performance and support compliance with the applicable industry and operational standards. The conversion process includes the implementation of technologies and equipment modifications developed with support from Axens, a leading global licensor of sustainable refining and biofuels technologies, which serves as a technology partner to XCF. These updates are intended to support the production of sustainable aviation fuel, while maintaining operational stability and yield efficiency. Planned and ongoing updates to the plant include: Catalyst Replacement: The Isomerization Reactor is being reloaded with fresh catalyst to ensure optimal performance. Equipment Modifications: Modifications intended to improve optimism and reduce the potential for spurious trips at turndown flow rates and ensure stability at SAF severity. Heat Exchange Improvements: A new heat exchanger is being installed to take advantage of heat recovery to enhance product throughput and quality. The catalyst delivery schedule is currently expected to proceed as planned, with the first catalyst anticipated to arrive by end of May 2026 and the second delivery of catalyst in early June 2026, supporting the anticipated commissioning of the plant in early June. The company expects these deliveries to support planned commissioning activities, subject to project conditions.
Trade with 70% Backtested Accuracy
Analyst Views on SAFX
About SAFX
About the author


- Financial Evaluation: Discussions are ongoing regarding the financial impact of evaluating notices.
- Involvement of Phillips: The evaluation process includes consultations with Phillips, indicating a collaborative approach.

Supply Termination: Global Inc. has announced the termination of its supply agreement with New Riser Renewables, effective May 1, 2026.
Offtake Agreement: The termination also includes an offtake agreement, indicating a significant shift in their business relationship.

Global Renewable Fuel Tolling Agreement: Global Inc. has entered into a renewable fuel tolling agreement with BGN, effective April 9, 2026.
SEC Filing: The details of this agreement have been filed with the SEC, indicating compliance with regulatory requirements.
- Earnings Highlights: XCF Global, Inc. reported a FY GAAP EPS of $0.52, indicating stable profitability amidst market challenges, which may reassure investors about the company's financial health.
- Revenue Performance: The company achieved revenue of $20.82 million, showing growth compared to the previous year, reflecting its competitive position in the market and sustained customer demand, which enhances confidence in future growth.
- Quant Rating Insight: Seeking Alpha's Quant Rating on XCF Global, Inc. provides an in-depth analysis of the company's financial health, aiding investors in understanding its market positioning and potential investment value.
- Historical Data Context: The historical earnings data for XCF Global, Inc. offers crucial context for analyzing its long-term performance, allowing investors to assess growth trends and future prospects.
- Earnings Beat: The Oncology Institute reported a Q4 loss of 6 cents per share, outperforming the analyst consensus estimate of a 9-cent loss, indicating improvements in cost management and operational efficiency, which boosts market confidence in its future profitability.
- Sales Growth: The company achieved quarterly sales of $141.957 million, exceeding the analyst consensus of $139.775 million, reflecting positive progress in market demand and product promotion, thereby strengthening its market position in oncology treatment.
- Stock Surge: Shares of The Oncology Institute jumped 14.7% to $3.01 in pre-market trading, demonstrating a positive investor reaction to the financial results, which may attract more investor interest in its future developments.
- Increased Market Confidence: The better-than-expected performance not only enhances investor confidence but may also prompt analysts to reassess the company's long-term growth potential, potentially influencing future stock price movements and market performance.







